Discovery of non-peptide inhibitors of Plasmepsin II by structure-based virtual screening

被引:11
作者
Song, Yuwei [1 ]
Jin, Huangtao [1 ]
Liu, Xiaofeng [1 ]
Zhu, Lili [1 ]
Huang, Jin [1 ]
Li, Honglin [1 ]
机构
[1] E China Univ Sci & Technol, Shanghai Key Lab New Drug Design, State Key Lab Bioreactor Engn, Sch Pharm, Shanghai 200237, Peoples R China
基金
中国国家自然科学基金;
关键词
Plasmepsin II; Anti-malaria; Virtual screening; Molecular docking; PLASMODIUM-FALCIPARUM; ASPARTIC PROTEASES; SUBSTITUTED PIPERIDINES; POTENT INHIBITORS; RENIN INHIBITORS; DESIGN; RESISTANCE; ENZYME;
D O I
10.1016/j.bmcl.2013.01.128
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Plasmepsin II (PM II) is an attractive target for anti-malaria drug discovery, which involves in host hemoglobin degradation in the acidic food vacuole. In this study, we demonstrated the successful use of structure-based virtual screening to identify inhibitors of PM II from two chemical database. Five novel non-peptide inhibitors were identified and revealed moderate inhibitory potencies with IC50 ranged from 4.62 +/- 0.39 to 9.47 +/- 0.71 mu M. The detailed analysis of binding modes using docking simulations for five inhibitors showed that the inhibitors could be stabilized by forming multiple hydrogen bonds with catalytic residues (Asp 34 and Asp 214) and also with other key residues. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2078 / 2082
页数:5
相关论文
共 31 条
[1]  
Asojo O.A., 2001, ACTA CRYSTALLOGR D, V2002, P58
[2]   Four plasmepsins are active in the Plasmodium falciparum food vacuole, including a protease with an active-site histidine [J].
Banerjee, R ;
Liu, J ;
Beatty, W ;
Pelosof, L ;
Klemba, M ;
Goldberg, DE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (02) :990-995
[3]   Structural studies of vacuolar plasmepsins [J].
Bhaumik, Prasenjit ;
Gustchina, Alla ;
Wlodawer, Alexander .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2012, 1824 (01) :207-223
[4]   Crystal Structures of the Histo-Aspartic Protease (HAP) from Plasmodium falciparum [J].
Bhaumik, Prasenjit ;
Xiao, Huogen ;
Parr, Charity L. ;
Kiso, Yoshiaki ;
Gustchina, Alla ;
Yada, Rickey Y. ;
Wlodawer, Alexander .
JOURNAL OF MOLECULAR BIOLOGY, 2009, 388 (03) :520-540
[5]   Inhibitors of aspartic proteases - potential antimalarial agents [J].
Boss, C ;
Corminboeuf, O ;
Grisostomi, C ;
Weller, T .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (03) :295-317
[6]   Development of a new class of inhibitors for the malarial aspartic protease plasmepsin II based on a central 7-azabicyclo[2.2.1]heptane scaffold [J].
Carcache, DA ;
Hörtner, SR ;
Seiler, P ;
Diederich, F ;
Dorn, A ;
Märki, HP ;
Binkert, C ;
Bur, D .
HELVETICA CHIMICA ACTA, 2003, 86 (06) :2173-2191
[7]   A new class of inhibitors for the malarial aspartic protease plasmepsin II based on a central 11-azatricyclo[6.2.1.02,7]undeca-2,4,6-triene scaffold [J].
Carcache, DA ;
Hörtner, SR ;
Bertogg, A ;
Diederich, F ;
Dorn, A ;
Märki, HP ;
Binkert, C ;
Bur, D .
HELVETICA CHIMICA ACTA, 2003, 86 (06) :2192-2209
[8]  
Carcache DA, 2002, CHEMBIOCHEM, V3, P1137, DOI 10.1002/1439-7633(20021104)3:11<1137::AID-CBIC1137>3.0.CO
[9]  
2-A
[10]   Aspartic proteases of Plasmodium falciparum and other parasitic protozoa as drug targets [J].
Coombs, GH ;
Goldberg, DE ;
Klemba, M ;
Berry, C ;
Kay, J ;
Mottram, JC .
TRENDS IN PARASITOLOGY, 2001, 17 (11) :532-537